News Articles

Galaxy To Build $50M Project In Worcester

Worcester Telegram & Gazette – August 2020
Galaxy Life Sciences LLC, whose sister company developed the Trolley Yard, has inked a deal to build an estimated $50 million building on a 6-acre plot at The Reactory biomanufacturing park. The deal also grants Galaxy Life Sciences the right to develop the remainder of the available lots in the biomanufacturing park on the former Worcester State Hospital campus. Read More

Galaxy LIfe Sciences Plans $50M+ Biomanufacturing Facility At The Reactory In Worcester

Worcester Business Journal – August 2020
"The need for flexible and sustainable biomanufacturing in the region has never been greater,” said Mike O’Brien, CEO of Galaxy Life Sciences. “We stand ready and able to help our potential life sciences partners turn their innovative ideas into commercial products at faster-than-industry-average speed to market". Read More

WuXi Biologics Hosts Virtual Ceremony on Zoom to Celebrate the Completion of Land Agreement and Start of Construction of Biopharmaceutical Manufacturing Facility at The Reactory in Worcester

June 16, 2020
A virtual ceremony on Zoom was held today to celebrate both the completion of the recent land agreement between WuXi Biologics (WuXi Bio) and the Worcester Business Development Corporation (WBDC), and the start of construction of the WuXi Bio MFG11 biopharmaceutical manufacturing facility at The Reactory in Worcester, Mass.

WuXi Biologics To Build $60 Million Biologics Production Facility

New England Real Estate Journal – June 2020
Worcester, MA WuXi Biologics (WuXi Bio), and Worcester Business Development Corp. (WBDC) have signed a land deal for WuXi Biologics’ clinical and commercial manufacturing facility (MFG11) at The Reactory, a 46-acre master-planned biomanufacturing campus. WuXi Biologics, a global company with leading open-access biologics technology platforms, empowers biopharma organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing. The $60 million, 107,000 s/f, two-story facility will be operational in 2022 and create 150 new jobs. Read More

Johnson & Johnson Partner’s Stock Soars As Investors Embrace China Health, Tech

Forbes - June 2020
“As the central Massachusetts biotech community continues its growth, WuXi Biologics’ arrival in Worcester will strengthen the sector and lead to ongoing economic development,” said Massachusetts Lt. Governor Karyn Polito. “Years of planning and collaboration to transform an unused property into a biomanufacturing hub has led to this exciting announcement today and I appreciate the commitment of so many to making this a reality.” Read More

WuXi Biologics Strikes Deal To Bring 8,000 L Single-Use Plant To MA

BioProcess International - May 2020
Along with several additional single-use biomanufacturing plants in China, WuXi Biologics set its sites on global expansion, first announcing plans for a 54,000 L plant in Ireland, then a 4,500 L fed-batch and perfusion-based facility in Singapore, and finally a site in in Worcester, Massachusetts, US. Read More

Tax Deal Endorsed For $60 million WuXi Biologics Project In Worcester

Worcester Telegram - March 2020
The City Council Economic Development Committee Monday night unanimously endorsed a 20-year tax increment financing plan for the project that would save the company roughly $11.5 million in property taxes over the life of the plan. During that period, the city would receive $20.7 million in new tax revenue from the project. Read More

TIF on the table for $60 million WuXi Biologics building in Worcester

Worcester Telegram - February 2020
After purchasing the land, Traynor said, the company will invest $60 million to construct a 107,000-square-foot facility on the site. He added that more than $40 million of the total investment is needed just for the company’s state-of-the-art equipment, as well as other furnishings and fit-out. Read More

Plans Advancing For Worcester’s Reactory Site

Worcester Business Journal - January 2020
The hulking old Bryan Building is finally gone. Marketing materials are out. A site plan for an anchor tenant has been approved. The Reactory, a planned biomanufacturing park off Belmont and Plantation streets in Worcester, is moving ahead as a potential major growth area for the city's attempts to gain a greater share of the state's life sciences industry. Read More

Biomanufacturing Site Plan OK’d In Worcester

Worcester Telegram - January 2020
The Planning Board Wednesday night unanimously approved a definitive site plan for a proposed $60 million biomanufacturing facility to be developed by WuXi Biologics, a global Chinese biomanufacturing company. The two-story, 110,000-square-foot building will be constructed in the new 46-acre biomanufacturing park at 305 Belmont St., known as The Reactory. It is on the site of the former Worcester State Hospital. Read More

Worcester Biotech Business Park Lands Financing for Site Preparation

Banker & Tradesman - December 2019
A planned biomanufacturing business park on the grounds of the former Worcester State Hospital is moving forward thanks to financing from Country Bank. The Worcester Business Development Corp. secured a $2.7 million loan from the Ware-based $1.5 billion-asset bank to fund site preparation efforts at The Reactory. The 46-acre complex has eight pads that can accommodate up to 530,000 square feet of development. The WBDC said in a statement. Read More

WuXi Builds Momentum For Worcester Biomanufacturing Park

Worcester Telegram - October 2019
At a meeting on Nov. 13, the board is scheduled to review a site plan for the first building to be constructed on the site: a roughly 110,000-square foot, two-story clinical and commercial research and manufacturing bio-pharmaceutical facility for WuXi Biologics, according to the application before the board. Blais said he and the company are still negotiating a final purchase-and-sale agreement but he hopes the company will begin construction in the spring and create 100 to 150 jobs. He said he anticipates the purchase and sale will be completed in mid-November. Read More

First Client In Works At ‘The Reactory’ Biomanufacturing On Former Worcester State Hospital Site

The Real Reporter - October 2019
The WBDC is in negotiations to secure the first tenant within The Reactory campus, WuXi Biologics, a Chinese contract development manufacturing organization. WuXi’s proposed $60 million facility would employ more than 150 people. In addition to WuXi’s interest, the WBDC is continuing its outreach efforts to identify and attract more biomanufacturing companies. Read More

Workforce, Infrastructure Seen As Keys To Biotech Growth

Worcester Telegram - June 2019
Building on groundwork laid decades ago, the life sciences sector here continues to thrive and evolve, and an event Monday night at Mechanics Hall hosted by the Massachusetts Biomedical Initiatives highlighted the past, the present and the future of the industry and its place in the city. Read More